$0.62
0.18% today
NYSE, Jul 02, 08:20 pm CET
ISIN
US9286611077
Symbol
VNRX
Sector

VolitionRX Share price

$0.62
-0.11 14.87% 1M
-0.10 13.67% 6M
-0.10 13.67% YTD
-0.79 56.10% 1Y
-2.58 80.66% 3Y
-2.50 80.16% 5Y
-0.93 60.06% 10Y
NYSE, Closing price Mon, Jul 01 2024
+0.01 2.31%
ISIN
US9286611077
Symbol
VNRX
Sector

Key metrics

Market capitalization $51.33m
Enterprise Value $44.10m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 55.13
P/S ratio (TTM) P/S ratio 64.16
P/B ratio (TTM) P/B ratio negative
Sales growth (TTM) Sales growth 133.06%
Turnover (TTM) Turnover $800.00k
EBIT (operating result TTM) EBIT $-35.33m
Free cash flow (TTM) Free cash flow $-18.42m
Cash position $11.77m
EPS (TTM) EPS $-0.46
P/E ratio expected negative
P/S ratio expected 17.86
EV/Sales expected 15.34
Short interest 0.79%
Show more

Is VolitionRX a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

VolitionRX Share analysis

Unlock Scores for Free

Analyst opinions

4 Analysts have issued a VolitionRX forecast:

3x Buy
75%
1x Hold
25%

Analyst opinions

4 Analysts have issued a VolitionRX forecast:

Buy
75%
Hold
25%

Financial data from VolitionRX

Assets
Mar '24
13 13
Cash position 12 12
Claims 0.13 0.13
Inventories - -
Other current assets Other current assets Current assets 1.56 1.56
5.96 5.96
Property, plant and equipment 5.75 5.75
Financial assets - -
Intangible assets 0.22 0.22
Other fixed assets Other assets Fixed assets - -
Total assets 19 19
Liabilities
Mar '24
Equity -17 -17
36 36
Current liabilities 31 31
Non-current liabilities 4.15 4.15
Total capital 19 19

Figures in millions USD.

Don't miss a thing! We will send you all news about the VolitionRX share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

VolitionRX Share News

Neutral
PRNewsWire
5 days ago
HENDERSON, Nev. , June 27, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a mid-year review to stockholders, ahead of its Annual Meeting of Stockholders to be held on July 2, 2024.
Neutral
Accesswire
18 days ago
ORLANDO, FL / ACCESSWIRE / June 14, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) ("Nexalin") and VolitionRX Limited (NYSE American:VNRX) ("Volition") on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 15, at 7 p.m. Eastern Time (ET).
Neutral
PRNewsWire
about one month ago
HENDERSON, Nevada , May 29, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that Cameron Reynolds, President and Group Chief Executive Officer, will present and be available for one-to-one meetings at the Jefferies Global Healthcare Conference in New York City. Presentation Details: Date: Wednesday, June 5, 2024 T...
More VolitionRX News

Company profile

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Head office United States
CEO Cameron Reynolds
Employees 110
Founded 1998
Website www.volition.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today